The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.
|
Our parent company, Jobson |
|
Medical Information LLC, is a leader in providing highly scientific healthcare, communications, information, and education. |
|
Press
CenterWatch is a leading publisher of news, directories, proprietary market research data, and analysis that serves clinical research professionals. We are a destination web site for clinical trials information and a service to educate patients about clinical research and potential studies that meet their health needs.
Learn more about us.
Additional Media Resources
- CenterWatch in the News
- Speaking Engagements
- Conference Attendance
- Editorial Team Bios
- Research Team Bios
CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content
CenterWatch, a leading provider of clinical trials information, received its fifth consecutive eHealthcare Leadership Award and seventh overall at the 10th Annual Healthcare Internet Conference held in Las Vegas last week. Presented by eHealthcare Strategy and Trends, a leading Internet publication, CenterWatch was awarded silver for Best Health/Healthcare Content.
Read more
CenterWatch to Discuss Critical Physician-Patient Relationship to Maximize Clinical Study Referrals at MAGI's Clinical Research Conference
Slow patient enrollment is one of the leading causes of delays in clinical trials with many studies missing deadlines nearly 90 percent of the time. In a presentation to industry professionals at MAGI's Clinical Research Conference in San Diego on Oct. 6, CenterWatch Senior Director and patient recruitment expert David Heck will discuss how physicians can right that lopsided statistic by educating patients about clinical trials and staying abreast of the drug development community.
Read more
CenterWatch Celebrates 15-Year Milestone as Leading Information Provider for the Clinical Trials Industry
CenterWatch, a leading provider of industry news, data analysis, and proprietary market research for clinical trials professionals and patients, turns 15 next month and will mark the occasion with a special, newly redesigned edition of it's flagship news publication, The CenterWatch Monthly.
Read more
CenterWatch Partners with TrialX to Dramatically Increase Reach of its Global Clinical Trial Listings to Many More Patients
CenterWatch, a leading source of clinical trials information, announced today that it has entered into a three-year partnership to share its clinical trials listing database with TrialX, a health information technology startup focused on helping patients more easily and rapidly connect with relevant clinical trials worldwide.
Read more
CenterWatch to Introduce Key Findings from Surveys on Physician Referrals to Clinical Trials and Clinical Trial Volunteer Experiences at DIA Meeting
CenterWatch, a global source for clinical trials information, will present never-before released results from two annual surveys aimed at better understanding physician referrals to clinical trials and study volunteer experiences at DIA's 45th Annual Meeting, June 22-24, 2009, in San Diego, Calif.
Read more
CenterWatch Announces May Release of State of the Clinical Trials Industry
CenterWatch, a global source for clinical trials information, announced today the planned release of its fifth edition of the annual sourcebook, State of the Clinical Trials Industry, due out in late May.
Read more
New CenterWatch Report Examines Japan's Surging Clinical Trials Market
In 2007, drug development in Japan, the world's second largest pharmaceutical market, exploded six-fold over 2006 and should continue to grow, according to a new CenterWatch report released today, Japan: Opening the Door to Global Clinical Trials.
Read more
CenterWatch to Reveal Key Findings of Global Investigative Site Survey at Baltimore Conference
CenterWatch, a global source for clinical trials information, will present results from four surveys aimed at examining the quality of relationships between sponsors and investigative sites from around the world at ExL Pharma's 4th Investigator Relationship Management conference to be held Feb. 23-24, 2009, in Baltimore, Md.
Read more
CenterWatch Wins Gold for Best Healthcare Content Third Year Running
CenterWatch, a global source for clinical trials information, announced today that it is the three-time recipient of the Gold eHealthcare Leadership Award for Best Health/Healthcare Content in the Other Healthcare Sites category presented by Strategic Health Care Communications. The award, given at the 12th Annual Healthcare Internet Conference in Orlando, Fla., marks the fourth consecutive year CenterWatch has been honored winning platinum in 2005.
Read moreCenterWatch Releases Special Report on Clinical Trial Development in Central and Eastern Europe
CenterWatch, a global source for clinical trials information, today announced the release of its latest report, Central and Eastern Europe: Outsourcing Trends and Growth Opportunities in Clinical Trials. The report explores the evolution of this region that has seen its growth in the industry triple in the last five years, making it the largest area for global clinical trial initiations outside of North America and Western Europe.
Read moreRapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
CenterWatch, a publishing and information services company focused on market research about clinical trials, finds in a new report that the Asia-Pacific region is grabbing an increasing share of the global clinical trial market, and with new regulatory changes across the region, has already been growing at more than 50% in recent years.
Read moreJobson Medical Information LLC Acquires CenterWatch™ and New England IRB From Thomson Healthcare
Jobson Medical Information LLC ("JMI"), a leading healthcare information and marketing services provider, announced that they had acquired the assets of CenterWatch and The New England Institutional Review Board ("NEIRB") from Thomson Healthcare Inc., a subsidiary of the Thomson Corporation. Terms of the transaction were not disclosed.
Read more
CenterWatch Tracks Emerging Markets of Clinical Research with Release of New Book
CenterWatch, which covers clinical research worldwide through its market research, newsletters and books, has been tracking the progress of pharmaceutical companies, biotech companies and contract research organizations as they expand their clinical research enterprise into emerging markets in an effort to improve drug development timelines. The percentage of Form FDA 1572s filed by investigators abroad has nearly doubled between 2001 and 2006, indicating a dramatic increase in global clinical trial participation by non-U.S. investigators.
Read moreThomson CenterWatch Publishes 2007 Edition of State of Clinical Trials Industry
The 2007 edition features more than 100 completely new charts analyzing the clinical research enterprise along with hundreds more updated slides from our 2006 edition.
Read more
Thomson CenterWatch Publishes 2006 Edition of State of Clinical Trials Industry
Thomson CenterWatch, a global publishing and information services company focused on clinical trials market research, releases its second annual edition of the top-selling sourcebook, State of the Clinical Trials Industry.
Read more
Thomson Centerwatch Provides Global Clinical Trial Protocol Registry and Results Database for Roche
Thomson, a global leader in providing integrated information solutions to scientific and healthcare customers, announced that its CenterWatch business entered into an agreement with Roche, one of the world’s leading research-focused groups in pharmaceutical and diagnostics. The agreement results in the transparent listing of Roche clinical trials information on two Web sites.
Read moreExpanding Central and Eastern European Clinical Research Market Gets Dedicated News Source
Thomson, a global leader in providing integrated information solutions to scientific and healthcare customers, and ICON plc, a global contract research organization, today announced the launch of a new electronic newsletter that sheds light on the quickly developing clinical research market in Central and Eastern Europe (CEE).
Read more
Skyscape and Thomson Centerwatch Make Clinical Trials Information Accessible to Physicians at The Point-Of-Care
Although more than 75 percent of pharmaceutical companies conduct clinical trials before getting FDA approval, useful trial information is not reaching the medical professionals who need it most. Skyscape today announced an agreement with Thomson CenterWatch to solve this problem by giving physicians PDA access to relevant facts on drugs in trials, patient eligibility and trial results.
Read moreIntegrated Clinical Trial Services, Through Alliance With Thomson CenterWatch, To Partner With Universal Meeting Management
Integrated Clinical Trial Services and Thomson CenterWatch Provide Continuing Medical Education Seminars in Partnership With Universal Meeting Management.
Read morewashingtonpost.com, Newsweek.com and CenterWatch to Increase Awareness of Medical Research with Launch of Clinical Trials Center
washingtonpost.com, Newsweek.com and Thomson CenterWatch today announced their collaboration on the Clinical Trials Center. This new advertorial section, hosted on washingtonpost.com and Newsweek.MSNBC.com, is the first of its kind among major news sites.
Read moreNovartis, AstraZeneca, and Merck Named Top Sponsors by European Researchers
Thomson, a global leader in providing integrated information solutions to scientific and healthcare customers, today announced results from a CenterWatch survey among 306 European investigative research centers (sites) evaluating their relationship with pharmaceutical and biotechnology companies that sponsor clinical research.
Read moreThomson CenterWatch and Integrated Clinical Trial Services to Offer New CME Symposia to Complement Patient Recruitment Initiatives
Thomson, a global leader in providing integrated information solutions to scientific and healthcare customers, announces that its CenterWatch business entered into a collaboration with Integrated Clinical Trial Services (ICTS). The agreement is designed to provide educational symposia to inform practice-based physicians and allied health professionals about the importance of communicating clinical trial information to their patients. These unique programs offer continuing medical education credits.
Read more
Thomson CenterWatch and NCERx Launch New Service Providing Clinical Trial Invitations to Research Volunteers
homson CenterWatch, a part of The Thomson Corporation, and NCERx announced today the launch of Volunteers Direct Network, a collaborative Internet-based service for patients interested in participating in clinical research studies. The new service (www.volunteersdirect.net) reaches a large and highly motivated group of patients with targeted invitations for them to participate in disease-specific clinical trials. Along with improving patient access to clinical trial information, the new service assists clinical research professionals in augmenting their subject recruitment efforts.
Read moreThomson CenterWatch Survey Reveals U.S. Clinical Researchers Rate GlaxoSmithKline, Eli Lilly and Pfizer Top Sponsors
Thomson CenterWatch, a part of The Thomson Corporation today released recent survey results showing GlaxoSmithKline, Eli Lilly and Pfizer are rated the top three pharmaceutical companies by the research centers that conduct their clinical trials.
Read moreDrug Information Association and CenterWatch establish agreement to deliver clinical research information and educational services to professionals around the world.
The Drug Information Association (DIA), and CenterWatch, a division of Thomson Healthcare, today announce a collaborative agreement to disseminate clinical trials information and resources to industry professionals worldwide. Through this agreement, DIA will distribute CenterWatch's award-winning news and information services to biopharmaceutical companies, regulatory agencies and other pharmaceutical and related healthcare industry professionals. Ultimately, this collaboration of complementary products, services, and constituents, will help advance international pharmaceutical research and development.
Read more
